CPH Insider Trading

Insider Ownership Percentage: 30.07%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Creso Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Creso Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Creso Pharma Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 01/1/2000 01:00 AM ET

This chart shows the closing price history over time for CPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Creso Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2023Bruce LintonInsiderIssued5,000,000A$0.02A$110,000.00
1/10/2023Bruce LintonInsiderIssued5,000,000A$0.04A$200,000.00
10/19/2022William LayInsiderBuy5,000,000A$0.03A$160,000.00
7/27/2022Boaz WachtelInsiderExpiry1,600,000A$0.05A$78,400.00
7/14/2021Adam BlumenthalInsiderIssued12,000,000A$0.13A$1,560,000.00
7/7/2021Adam BlumenthalInsiderSell32,833,333A$0.14A$4,498,166.62
See Full Table

SEC Filings (Institutional Ownership Changes) for Creso Pharma (ASX:CPH)

0.01% of Creso Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Creso Pharma logo
Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
Read More on Creso Pharma

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.62

Who are the company insiders with the largest holdings of Creso Pharma?

Creso Pharma's top insider investors include:
  1. Boaz Wachtel (Insider)
  2. Bruce Linton (Insider)
  3. William Lay (Insider)
Learn More about top insider investors at Creso Pharma.